pillbase.ru

Aspaveli

Active substance: pegcetacoplan

pegcetacoplan

Centralised EU authorisationActive

Marketing holder: Swedish Orphan Biovitrum AB (publ)

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • Empaveli
    INJECTION, SOLUTION · PEGCETACOPLAN 1080 mg/20mL
    73606-010
    Apellis Pharmaceuticals, Inc.
  • Syfovre
    INJECTION, SOLUTION · PEGCETACOPLAN 15 mg/.1mL
    73606-020
    Apellis Pharmaceuticals, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2f03-7331-aef2-035d6c8fe029,01a12095-1da8-7af7-a25d-d51104657b2b;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005553
Registration status
Active
ATC code
L04AJ03
Sources
  • product · EMA · EMEA/H/C/005553 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005553 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005553 · Verified 2026-10-09